Investegate |Open Orphan PLC Announcements | Open Orphan PLC: Notice of results
Investegate announcements from Open Orphan PLC, Notice of results
Stay updated with breaking news from Open Orphan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Open Orphan PLC, Notice of results
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan, has signed a £10.4m contract with an existing top 5 global ...
Open Orphan £10.4m contract with existing Big Pharma client
Yamin Khan, CEO of Open Orphan, said Influenza causes an estimated 290,000 to 650,000 deaths per year with ‘significant pandemic potential’.
/PRNewswire/ -- Pneumagen, a clinical stage biotech company developing Neumifil, an intranasal, broad-spectrum antiviral treatment to prevent or, if infected...